Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pcDNA3-deltaOVA Citations (2)

Originally described in: MHC class II presentation of endogenously expressed antigens by transfected dendritic cells.
Diebold SS, Cotten M, Koch N, Zenke M Gene Ther. 2001 Mar;8(6):487-93.
PubMed Journal

Articles Citing pcDNA3-deltaOVA

Articles
Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells. Tay RE, Olawoyin O, Cejas P, Xie Y, Meyer CA, Weng QY, Fisher DE, Long HW, Brown M, Kim HJ, Wucherpfennig KW. J Exp Med. 2020 Jul 6;217(7). pii: 151741. doi: 10.1084/jem.20191453. PubMed
Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells. Anadon CM, Yu X, Hanggi K, Biswas S, Chaurio RA, Martin A, Payne KK, Mandal G, Innamarato P, Harro CM, Mine JA, Sprenger KB, Cortina C, Powers JJ, Costich TL, Perez BA, Gatenbee CD, Prabhakaran S, Marchion D, Heemskerk MHM, Curiel TJ, Anderson AR, Wenham RM, Rodriguez PC, Conejo-Garcia JR. Cancer Cell. 2022 May 9;40(5):545-557.e13. doi: 10.1016/j.ccell.2022.03.008. Epub 2022 Apr 14. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.